Roivant Sciences Ltd.

IMVT

Roivant Sciences Ltd. serves as an insider at Immunovant, Inc. (IMVT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$747.40M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$747.40M

Companies Traded

ROIV, IMVT

Active Period

Oct 2022 – Dec 2025

4 total trades

Most Recent

Buy ROIV

Dec 12, 2025 · $350.00M

Roivant Sciences Ltd.'s Insider Trading at Immunovant, Inc. (IMVT)

Buys

3 · $397.40M

Sells

0 · $0.00

Total Shares Bought

18,787,993

Total Shares Sold

IMVT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 15, 2025	Buy	16,845,010	$20.00	$336.90M	96,650,344
Oct 4, 2023	Buy	1,526,316	$38.00	$58.00M	79,805,328
Oct 7, 2022	Buy	416,667	$6.00	$2.50M	73,805,328

Roivant Sciences Ltd.'s Insider Trading at Roivant Sciences Ltd. (ROIV)

Buys

1 · $350.00M

Sells

0 · $0.00

Total Shares Bought

16,666,666

Total Shares Sold

ROIV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 12, 2025	Buy	16,666,666	$21.00	$350.00M	113,317,008

Related Insiders

Tuyl Christopher Van

officer: Chief Legal Officer

IMVTSell · Mar 20, 2026

Melanie Gloria

officer: Chief Operating Officer

IMVTSell · Feb 27, 2026

Frank Torti

President and Vant Chair

ROIVSell · Feb 19, 2026

Eric Venker

President & Immunovant CEO

ROIVSell · Feb 13, 2026

Jay S Stout

Chief Technology Officer

IMVTSell · Jan 21, 2026

Douglas J. Hughes

Director

IMVTSell · Dec 1, 2025

Andrew J. Fromkin

Director

IMVTSell · Dec 1, 2025

Michael Geffner

Chief Medical Officer

IMVTSell · Oct 22, 2025

Explore More Insider Trading Data

IMVT Insider Trading Activity

View all insider trades at Immunovant, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity